☆ 4.6 Review

Development of bullous pemphigoid during treatment of psoriasis with ustekinumab: a case report and literature review

FRONTIERS IN MEDICINE (2023)

Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review

Husein Husein-ElAhmed et al.

Summary: This study accurately estimates the burden of BIBP, with ustekinumab presenting the most evidence of BIBP. Different cytokine pathways and clinical course patterns exist between BPs induced by TNF-alpha blockers and ustekinumab. Prior to commencing any biologic therapy, a careful screening of previous history of bullous diseases and baseline immunologic study in psoriatic patients is advisable.

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

Bullous pemphigoid induced by ustekinumab: a case report

Marta Marin et al.

Summary: A case of possible bullous pemphigoid (BP) associated with ustekinumab treatment was reported in a 75-year-old woman. The patient presented with new lesions shortly after receiving the fifth dose, which resolved with corticosteroid and dapsone treatment. Three causality algorithms suggested a probable causal relationship, highlighting the importance of considering drug side effects in prescribing therapies.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2021)

添加到收藏夹

Letter Dermatology